-- Completed enrollment in Part B of SIGNAL-AA Phase 2a clinical trial and increased trial size to 33 patients based on patient demand; 36-week topline data readout expected in mid-2026 -- -- ...
Repay Holdings Corp (RPAY) reports robust Q4 2025 results with significant business payments growth, despite facing hurdles in the consumer payment segment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results